Alternatives to C4 Therapeutics
C4 Therapeutics is a Biotech tool: biopharmaceutical company developing novel cancer therapies using targeted protein degradation. Here are the 59 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to C4 Therapeutics
EnteroBiotixNot ratedDeveloping microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.
BiotechnologyPharmaceuticalsUpdated 1 Jul 2026
Latus BioNot ratedEngineering scalable gene therapies for broader patient populations.
BiotechnologyGene TherapyUpdated 16 Sept 2026
BeiGeneNot ratedA global oncology company developing and commercializing innovative cancer treatments.
BiotechMedTechUpdated 1 Jul 2026
Cue Biopharma, .Not ratedDeveloping engineered biologics to harness the immune system for disease treatment.
BiotechDrug DiscoveryUpdated 13 Sept 2026
Caris Life SciencesNot ratedCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
BiotechMedTechUpdated 25 Jun 2026
Guardant HealthNot ratedGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
BiotechMedTechUpdated 28 Sept 2026- PRProNAi TherapeuticsNot rated
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
BiotechDrug DiscoveryUpdated 23 Aug 2026
ProteinQureNot ratedBiotech company using AI and computational platforms to design novel peptide therapeutics.
BiotechDrug DiscoveryUpdated 7 Sept 2026
TharimmuneNot ratedBiotechnology company developing novel immunotherapies for cancer.
BiotechMedTechUpdated 1 Jul 2026
Leap TherapeuticsNot ratedLeap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.
BiotechHealthTechUpdated 25 May 2026
Adicet Bio3.0 out of 5 (1)Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
BiotechHealthTechUpdated 30 Aug 2026- ONOneThree BiotechNot rated
AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.
BiotechHealthTechUpdated 1 Jul 2026 - ALAlpha9 TheranosticsNot rated
Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.
BiotechMedTechUpdated 14 May 2026
32 Biosciences1.0 out of 5 (1)Develops novel therapeutic antibodies for oncology and autoimmune diseases.
BiotechDrug DiscoveryUpdated 29 Sept 2026
Intellia TherapeuticsNot ratedA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
BiotechMedTechUpdated 30 Aug 2026
Sutro BiopharmaNot ratedClinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.
BiotechDrug DiscoveryUpdated 26 Sept 2026
CureVacNot ratedBiopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.
BiotechMedTechUpdated 21 Jun 2026
Amgen3.0 out of 5 (1)A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
BiotechMedTechUpdated 1 May 2026
Adaptive BiotechnologiesNot ratedLeveraging the adaptive immune system to diagnose and treat disease.
BiotechHealthTechUpdated 1 Jul 2026
SynthaceNot ratedSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
BiotechMedTechUpdated 23 Aug 2026
Showing the 20 closest matches. See the rest on the C4 Therapeutics profile.